Your search returned 18 studies. (Get alerts for new studies):
- Cetuximab and Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
4 Locations available
- AZD2171 in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
1 Location available
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
420 Locations available
- Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors
Conditions: Head and Neck Cancer
18 Locations available
- Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)
Conditions: Squamous Cell Cancer - Head and Neck Cancer
5 Locations available
- Docetaxel And Cisplatin With or Without Erlotinib For Metastatic Or Recurrent Squamous Cell Carcinoma Of Head And Neck
Conditions: Head and Neck Cancer - Squamous Cell Carcinoma of the Head and Neck
1 Location available
- A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Conditions: Head and Neck Neoplasms
23 Locations available
- Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma
Conditions: Head and Neck Cancer
1 Location available
- Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
Conditions: Anal Cancer - Breast Cancer - Esophageal Cancer - Gastric Cancer - Head and Neck Cancer - Lung Cancer - Nonneoplastic Condition - Ovarian Cancer - Unspecified Adult Solid Tumor, Protocol Specific
6 Locations available
- Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy
Conditions: Head and Neck Cancer
22 Locations available
- Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
9 Locations available
- Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
1 Location available
- TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
1 Location available
- MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
3 Locations available
- Cetuximab and Interleukin-12 in Treating Patients With Head and Neck Cancer That is Recurrent, Metastatic, or Cannot Be Removed By Surgery
Conditions: Head and Neck Cancer
1 Location available
- Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer
Conditions: Head and Neck Squamous Cell Carcinoma
1 Location available
- Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
1 Location available
- Intensity-Modulated Radiation Therapy, Pemetrexed Disodium, and Erlotinib Hydrochloride in Treating Patients With Recurrent or Second Primary Head and
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell Carcinoma of the Larynx - Recurren
2 Locations available
|